Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name INMUNE BIO, INC Proposed Ticker INMB CUSIP N/A Business Description A pharmaceutical clinical stage immunotherapy company focused on developing pioneering strategies for oncology that focus on re-engineering and harnessing the innate immune system to treat the patient’s cancer Lead Underwriter Univest Securities, LLC Co-Managers N/A Initial Shares 25,00,000 Revised Initial Shares N/A Initial Price $8.00-$8.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.